Clinical Study

Nrg-Bn003- Phase III Trial Of Observation Versus Irradiation For A Gross Totally Resected Grade II Meningioma

Posted Date: May 15, 2019

  • Investigator: Kyle Wang
  • Specialties: Cancer, Oncology
  • Type of Study: Observational/Survey

The goal of this study is to determine the extent of clinical benefit of the addition of adjuvant radiotherapy (RT) to gross total resection (GTR) for patients with newly diagnosed World Health Organization (WHO) grade II meningioma.


To Be Eligible: Diagnosed Grade Ii Meningioma, Age 18 Or Older, No Prior Malignancy In Last 3 Years


Brain Cancer, Cancer, Meningioma, Nrg-Bn003, Phase Iii

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.